朗威股份 reported revenue of ¥0.84B for the period ended 2026-06-30, +39.8% year on year. Net income was ¥0.04B, a 4.2% net margin on a 18.5% gross margin. The largest revenue line is 数据中心机柜 at 43% of the total. Free cash flow for the period was ¥-0.05B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.84B | +39.8% |
| Gross profit | ¥0.16B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.04B | -19.0% |
| Gross margin | 18.5% | Net margin 4.2% |
| Revenue Q/Q | +68.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 数据中心机柜 | ¥0.37B | 43.4% |
| 综合布线产品 | ¥0.35B | 41.3% |
| 其他定制机柜 | ¥0.11B | 13.3% |
| 其他(补充) | ¥0.02B | 2.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.69B | 81.5% |
| R&D | ¥0.02B | 2.5% |
| SG&A | ¥0.06B | 7.1% |
| Tax & other | ¥0.02B | 1.8% |
| Item | Amount |
|---|---|
| Total assets | ¥2.16B |
| Total liabilities | ¥0.96B |
| Shareholders' equity | ¥1.20B |
| Equity / assets | 55.6% |
| Operating cash flow | ¥-0.03B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥-0.05B |
| Cash conversion (OCF / net income) | -297% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
国泰环保 ・ 联特科技 ・ 三元生物 ・ 华兰疫苗 ・ 中亦科技 ・ 联合化学 ・ 金杨精密 ・ 亨迪药业 ・ 联盛化学 ・ 观想科技 ・ 中汽股份 ・ 万凯新材
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies